For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for PepsiCo, Inc. (PEP) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-07): Designation Watch · Gem Score -7 (−100…+100 Quality+Value blend) · Quality 46 · Value -43 · Sentiment 17 (timing only, not weighted) · Composite fair value $113.74 vs $141.07 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
PepsiCo, Inc.
PEP NASDAQPepsiCo, Inc. is a global food and beverage company that manufactures, markets, and distributes a broad portfolio of beverages, snacks, and convenient foods worldwide. Headquartered in Purchase, New York, PepsiCo focuses on branded products that span carbonated soft drinks, sports and energy beverages, juice drinks, bottled water, ready-to-drink teas and coffees, and home carbonation systems. In convenient foods, the company offers salty snacks, cereals, granola bars, rice and pasta products, baking mixes, and other pantry staples under well-known brands such as Lay’s, Doritos, Cheetos, Quaker, Gatorade, Pepsi, and Mountain Dew. PepsiCo organizes its operations across multiple geographic and product-based segments, including dedicated North American food and beverage units and regional divisions covering Latin America, Europe, Asia Pacific, the Middle East, and Africa. Its products reach consumers through a mix of direct store delivery, customer warehouse, foodservice, vending, and e-commerce channels, serving retailers, wholesalers, foodservice operators, and online platforms in more than 200 countries and territories. Founded in 1965 and based in the United States, PepsiCo today plays a central role in the global market for branded beverages and convenient foods.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 6.00
Total Equity: $20.55B
Shares: 1,373,000,000
Total Debt: $49.18B
Cash: $9.16B
EBITDA: $14.95B
Total Debt: $49.18B
Cash: $9.16B
Revenue: $93.93B
Revenue: $93.93B
Revenue: $93.93B
Total Equity: $20.55B
Tax Rate: 19.0%
Equity: $20.55B
Total Debt: $49.18B
Cash: $9.16B
Current Liabilities: $32.76B
Long-Term Debt: $42.32B
Total Debt: $49.18B
Total Equity: $20.55B
Shares: 1,373,000,000
Shares: 1,373,000,000
CapEx: -$4.42B
Shares: 1,373,000,000
Stock Price: $139.02
Net Income: $8.24B
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 9, 2026 12:26am (59d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $79.5B | $86.4B | $91.5B | $91.9B | $93.9B |
| Cost of Revenue | $37.1B | $40.6B | $41.9B | $41.7B | $43.1B |
| Gross Profit | $42.4B | $45.8B | $49.6B | $50.1B | $50.9B |
| Operating Expenses | $31.2B | $34.3B | $37.6B | $37.2B | $39.4B |
| Operating Income | $11.2B | $11.5B | $12.0B | $12.9B | $11.5B |
| Net Income | $7.6B | $8.9B | $9.1B | $9.6B | $8.2B |
| EBITDA | $13.9B | $14.3B | $14.9B | $16.0B | $14.9B |
| EPS | $5.51 | $6.45 | $6.59 | $6.97 | $6.02 |
| EPS (Diluted) | $5.49 | $6.42 | $6.56 | $6.95 | $6.00 |
Balance Sheet (Annual)
Last updated: Jul 31, 2026 9:18am (68d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5.6B | $5.0B | $9.7B | $8.5B | $9.2B |
| Total Current Assets | $21.8B | $21.5B | $27.0B | $25.8B | $27.9B |
| Total Assets | $92.4B | $92.2B | $100.5B | $99.5B | $107.4B |
| Current Liabilities | $26.2B | $26.8B | $31.6B | $31.5B | $32.8B |
| Long-Term Debt | $36.0B | $35.7B | $37.6B | $37.2B | $42.3B |
| Total Liabilities | $76.2B | $74.9B | $81.9B | $81.3B | $86.9B |
| Total Equity | $16.2B | $17.3B | $18.6B | $18.2B | $20.5B |
| Retained Earnings | $65.2B | $67.8B | $70.0B | $72.3B | $72.8B |
Cash Flow (Annual)
Last updated: Aug 9, 2026 12:26am (59d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $11.6B | $10.8B | $13.4B | $12.5B | $12.1B |
| Capital Expenditure | -$4.6B | -$5.2B | -$5.5B | -$5.3B | -$4.4B |
| Free Cash Flow | $7.0B | $5.6B | $7.9B | $7.2B | $7.7B |
| Acquisitions (net) | — | — | — | — | — |
| Net Debt Issued / (Repaid) | $667.0M | $919.0M | $2.5B | $156.0M | $4.1B |
| Dividends Paid | -$5.8B | -$6.2B | -$6.7B | -$7.2B | -$7.6B |
| Stock Buybacks | -$106.0M | -$1.5B | -$1.0B | -$1.0B | -$1.0B |
| Net Change in Cash | -$2.5B | -$607.0M | $4.7B | -$1.2B | $651.0M |
Growth Trends (YoY %)
Last updated: Aug 9, 2026 12:26am (59d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +8.7% | +5.9% | +0.4% | +2.3% |
| Gross Profit Growth | +8.1% | +8.2% | +1.0% | +1.5% |
| Operating Income Growth | +3.1% | +4.1% | +7.5% | -10.8% |
| Net Income Growth | +17.0% | +1.8% | +5.6% | -14.0% |
| EBITDA Growth | +2.9% | +4.6% | +7.5% | -6.8% |
Dividend History (Last 20)
Last updated: Aug 9, 2026 12:07am (59d ago)| Date | Dividend | Declaration | Record | Payment |
|---|---|---|---|---|
| 2026-09-04 | $1.48 | — | — | — |
| 2026-06-05 | $1.48 | — | — | — |
| 2026-03-06 | $1.42 | — | — | — |
| 2025-12-05 | $1.42 | — | — | — |
| 2025-09-05 | $1.42 | — | — | — |
| 2025-06-06 | $1.42 | — | — | — |
| 2025-03-07 | $1.36 | — | — | — |
| 2024-12-06 | $1.36 | — | — | — |
| 2024-09-06 | $1.36 | — | — | — |
| 2024-06-07 | $1.36 | — | — | — |
| 2024-02-29 | $1.27 | — | — | — |
| 2023-11-30 | $1.27 | — | — | — |
| 2023-08-31 | $1.27 | — | — | — |
| 2023-06-01 | $1.27 | — | — | — |
| 2023-03-02 | $1.15 | — | — | — |
| 2022-12-01 | $1.15 | — | — | — |
| 2022-09-01 | $1.15 | — | — | — |
| 2022-06-02 | $1.15 | — | — | — |
| 2022-03-03 | $1.08 | — | — | — |
| 2021-12-02 | $1.08 | — | — | — |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-10-06 02:03A +1σ run of quarters pays -8%; a −1σ run costs 46%. Ratio -0.2:1 (μ 4.3%, σ 3.8% , 16 pairs).
Older method (repeat-worst-quarter): 0.7 : 1
| Case | Growth | Margin | Fair value | vs price ($141.07) |
|---|---|---|---|---|
| Bull — recovery | +7% | 17.3% | $176.91 | +25% |
| Base — stabilizes | +5% | 15.0% | $143.93 | +2% |
| Bear — keeps slipping | +2% | 12.8% | $114.79 | -19% |
| Stress — last quarter repeats | +3% | 9.7% | $90.55 | -36% |
| Upside — a +1σ run of quarters (v2) | +8% | 11.9% | $129.82 | -8% |
| Stress — a −1σ run of quarters (v2) | +1% | 8.7% | $76.35 | -46% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-31 03:28The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
Looking at the raw numbers first: PEP's five-year revenue CAGR is a genuine 4.3% ($79.5B→$93.9B), but the more recent trajectory has flattened hard — 2023→2024→2025 goes $91.5B→$91.9B→$93.9B, essentially inflation-driven pricing with no volume. Net income is worse: $9.58B (2024) → $8.24B (2025), a 14% decline, and the quarterly margin series is genuinely noisy (5.5%, 12.6%, 10.2%, 5.6%, 10.9%, 8.7%, 12%, 12.3%) suggesting recurring restructuring/impairment charges rather than clean earnings power. FCF of $7.67B against a $192.7B market cap is a 4% FCF yield — thin for a no-growth business. The payout ratio at 92.7% with a 4.11% dividend yield is the load-bearing wall of the thesis; if earnings slip another 10%, the dividend narrative cracks. Debt/equity of 2.39 and current ratio 0.85 aren't alarming for a staple, but the $49B debt load limits buyback flexibility.
On the prior models: the synthesis fair value of $85-108 vs. $141 feels directionally right but the low end is aggressive. A 4% FCF yield on $7.67B capitalized at a staples-appropriate 5.5-6% discount rate (reflecting the bond-proxy nature) gets you closer to $128-140B enterprise value, or roughly $85-95/share equity after netting $40B net debt — so the synthesis's $85 signal-adjusted number is defensible on a strict DCF, but ignores that PEP has historically traded at premium multiples for a reason (distribution moat, Frito-Lay's genuine pricing power in salty snacks where private label has failed for 40 years). Market Forces calling this a "deteriorating business facing structural demand destruction from GLP-1" is overwrought — Frito-Lay volumes have softened but haven't collapsed, and the GLP-1 thesis has been front-page for two years without showing up meaningfully in Pepsi's revenue line. That's either a slow-burn thesis or a wrong one; skepticism warranted either way.
The contrarian case worth taking seriously: PEP screens as overvalued on every backward-looking metric, but the H1 2026 prints ($24.18B and $19.44B revenue, 12.3% and 12% margins) are the best margin quarters in the dataset. If that persists — and it's only two quarters, so it might not — full-year 2026 could hit $95-97B revenue with $10-10.5B net income, putting forward P/E closer to 19x rather than 23.5x trailing. That's still not cheap, but it's not egregious for a KO/PEP-caliber franchise, and it would falsify the "deteriorating business" narrative. The insider activity is noise — the 900,000-share J-Other is almost certainly a trust/estate transfer, not a sale, and there's only one small S-Sale (2,900 shares). Market Forces overstates the insider signal.
Where I land: the models are directionally correct that PEP is expensive relative to its actual growth (1.3% revenue CAGR, -4.7% earnings CAGR is not a compounder, it's a stagnator with a dividend), but the fair-value anchors of $85-108 embed too much pessimism about the franchise durability. My read is fair value $110-120 — a genuine 15-20% overvaluation, not a 40% one. The narrative-economics framing is the most useful prior output: this is a bond-proxy trading on TINA demand from dividend indexers, and the risk isn't that Frito-Lay collapses, it's that a 10-year yield above 5% or two more quarters of earnings declines break the "sleep well" spell and force a re-rate to a 5% FCF yield ($153B market cap, ~$112/share). I dissent from the synthesis's magnitude but agree on direction. This is a hold-if-you-own-it, don't-initiate-here name; the asymmetry doesn't work at $141 when $115 is a plausible mean-reversion target on any earnings disappointment, and upside requires the H1 2026 margin recovery to persist for three more quarters — a real bet, not a lock.
GPT Reading
At $141, PepsiCo is being valued like a very stable compounder at a moment when the actual business looks more like a low-growth, margin-pressured staple. The revenue line is not broken, but it is clearly not doing enough to justify a premium multiple: sales went from $91.47B in 2023 to $91.85B in 2024 and $93.93B in 2025, just 2.3% growth last year and roughly 1.3% CAGR over the multi-year window. Meanwhile earnings have moved the wrong way. Net income was $9.58B in 2024 and fell to $8.24B in 2025, and quarterly profit has been choppy to weak: the latest four quarters sum to about $8.71B, still below the prior annual peak. The most recent reported quarter was decent on the surface at $24.18B of revenue and $2.98B of net income, but that follows a year where June-quarter margin cratered to 5.6% and the December quarter was only 8.7%. For a business sold as a fortress, the earnings consistency is not especially fortress-like right now.
The cash flow and balance sheet reinforce that this is a mature business with limited room for valuation error. Free cash flow of $7.67B against a $192.7B market cap is roughly a 4.0% FCF yield, not compelling for a company with basically flat real growth and some recent earnings deterioration. Debt of $49.18B against $9.16B of cash leaves substantial net leverage, and the capital structure matters because this is not a business where you can wave away a weak current ratio of 0.85 and debt/equity of 2.39 as irrelevant. Return metrics are still good — ROIC of 15.4% is real evidence of brand and distribution strength — but part of the gaudy 40.1% ROE is just leverage and a thin $20.55B equity base, not pure operating brilliance. Add a dividend yield of 4.1% but a payout ratio of 92.7%, and the picture is a company still capable of paying shareholders well, yet with far less cushion than the “bond substitute” crowd tends to assume.
That is why I do not buy the more dramatic “structural collapse” framing, but I also think the market is overpaying for safety. PepsiCo is still producing gross margin above 54%, operating cash flow above $12B, and quarterly revenue that continues to edge upward; this is not a melting ice cube in the sense of imminent economic decay. The food-and-beverage mix is genuinely resilient, and the latest two quarters — $19.44B and $24.18B of sales with 12.0% and 12.3% net margins — suggest management can still restore profitability after the softer 2025 periods. If you annualize the latest four quarters, revenue is roughly $96.9B, so there is some evidence of modest top-line progression beyond the annual 2025 print. A smart bull would also point out that 23.5x earnings is not insane for a global staples franchise with a 4% yield, especially if rates ease and investors keep paying up for durability.
But I weigh those positives differently because the stock already reflects them and then some. On 2.06x sales, 15.6x EV/EBITDA, and 23.5x earnings, you are not buying a turnaround multiple or even a plain defensive multiple; you are buying a premium franchise multiple despite revenue barely outgrowing inflation and net income shrinking. The latest annual operating income of $11.50B was down from $12.89B the prior year despite higher sales, which tells you the core issue is not demand collapse but weaker profit conversion. That matters because this investment case depends on pricing power and margin stability. If those are wobbling, the premium should compress. I do not see evidence here that deserves a panic bear case, but I do see enough to say fair value is materially below the current quote — more in the $115-$125 range, where the dividend and quality would compensate for the slow growth and leverage.
What would change my mind is straightforward. If PepsiCo can put up two or three consecutive quarters with revenue growth above 4%, net margin sustainably back above 11%-12%, and full-year free cash flow recovering into the $9B-$10B range without leverage worsening, then the premium multiple becomes easier to defend. I would also soften if annual operating income decisively reclaims and exceeds the 2024 level of $12.89B, because that would show 2025 was a temporary margin air pocket rather than a new earnings base. Conversely, if revenue stays stuck near 1%-2% growth while net income remains sub-$8.5B and the payout ratio stays near 90%+, then even $125 may prove too generous.
Grok Reading
PepsiCo’s raw numbers describe a high-quality franchise that has stopped compounding. Annual revenue crawled from $91.85B in 2024 to $93.93B in 2025 (+2.3%), while net income fell from $9.58B to $8.24B and operating income dropped from $12.89B to $11.50B. The multi-year picture is worse: revenue CAGR of only 1.3% against an earnings CAGR of –4.7% and FCF CAGR of –1.6%. Free cash flow remains real at $7.67B on $12.09B of operating cash, yet the 92.7% payout ratio leaves almost no retained earnings buffer, and the balance sheet carries $49.18B of debt against $20.55B of equity (D/E 2.39) with a sub-1.0 current ratio. At $141 the stock trades 23.5× trailing earnings, 15.6× EV/EBITDA and 9.4× book for a business whose recent quarterly net margins have swung between 5.6% and 12.3% and whose volume growth is essentially flat. The quantitative models that call this overvalued are directionally correct; the cash flows simply do not support a mid-20s multiple when both earnings and free cash flow are contracting.
The strongest counter-argument is that PepsiCo still prints mid-teens ROIC (15.4%), holds a 54% gross margin, and generates enough cash to fund a 4.1% dividend yield that retirement and staples flows treat as a bond substitute. The dual beverage-and-snacks moat, pricing power across 200 countries, and recession resilience are not imaginary, and the “steady-compounder” narrative has proven durable for decades. A bull can also note that 2025’s earnings drop may contain one-time noise and that the most recent two quarters restored double-digit net margins ($2.33B and $2.98B NI). Those points justify a premium to pure value, yet they do not justify a 65% gap between the ~$85–108 fundamental range implied by the cash flows and the $141 market price, especially when GLP-1 and health-trend headwinds are already visible in decelerating volume.
I would reverse the overvalued call only if the next two reported quarters show organic volume growth re-accelerating above 3%, operating margin stabilizing above 13%, and free-cash-flow coverage of the dividend moving comfortably below an 80% payout—evidence that pricing power is translating into real unit growth rather than just margin defense.
Qwen Reading local experiment · off-panel
The number that jumps out at me isn't the 23x trailing P/E or the 1.3% revenue CAGR — it's the Q2 2025 margin of 5.6% sitting in the middle of an otherwise 10-12% margin band, and the fact that both 2026 quarters have already recovered to 12.0% and 12.3%. The 2025 annual net income of $8.24B, which the momentum layer flags as a -14% YoY decline, is almost entirely an artifact of that single quarter. Annualize the first half of 2026 ($2.98B + $2.33B = $5.31B) and you get roughly $10.6B of run-rate earnings, which puts the stock at about 18x forward, not 23x trailing. The Valuation Synthesis layer's $95.81 signal-adjusted fair value implies a multiple in the low-teens on a company generating $12.09B in operating cash flow and $7.67B in free cash flow with a 15.4% ROIC. I don't think that's a defensible anchor. The Market Forces layer's "GLP-1 structural decline" framing is, frankly, a stretch for a company where Frito-Lay and Quaker are as large as Pepsi Beverages; revenue is still growing 2.3% YoY in the most recent quarter, not contracting.
What I do take seriously is the balance sheet and the capital allocation constraint. $49.18B of total debt against $20.55B of equity is a 2.4x leverage ratio that is high for a consumer staples name, and the current ratio of 0.853 means current liabilities exceed current assets — a genuine liquidity tightness that the "fortress balance sheet" narrative glosses over. More importantly, the 92.7% payout ratio means PepsiCo is returning essentially all of its $7.67B FCF as dividends, leaving almost nothing for buybacks, debt paydown, or M&A. The 4.18% dividend yield is well-covered by operating cash flow, but the company has no financial flexibility if a commodity cost spike or an emerging-market FX shock hits simultaneously. The insider tape is unremarkable — a handful of small A-Award grants, one trivial 2,900-share sale, and two large J-Other entries (900,000 and 79,731 shares) that are too ambiguous to read as either conviction or distribution. There is no insider signal here, in either direction.
The strongest case against my read is the trajectory, not the level. Revenue CAGR of 1.3% over five years is effectively zero growth; the 8.7% jump in 2022 was inflation-driven price increases, not volume. Operating margin has compressed from 14.0% in 2021 to 12.2% in 2025, and even the 2026 recovery to 12.3% is below the 2021-2023 range. A smart bear would point out that the 2026 margin "recovery" could be a one-year commodity tailwind (palm oil, sugar, aluminum) that reverses in 2027, and that the 93% payout ratio means management has already committed the cash flow to the dividend, so any margin wobble hits the balance sheet directly rather than being absorbed by a buyback cushion. I weigh this differently because the 2026 quarters show the margin recovery is broad-based across both H1 periods, not a single-quarter fluke, and because a 15.4% ROIC on a $94B revenue base is still well above the cost of capital even in a zero-growth scenario.
The stock's 19% drawdown from $171 to $139 has already done a lot of the de-rating work. At $139, you're paying 2.03x sales, 15.4x EV/EBITDA, and getting a 4.0% FCF yield plus a 4.2% dividend — a combined ~8% cash return that is competitive with a 10-year Treasury in a falling-rate environment but unexciting in a rising-rate one. I don't see a 30% downside case to $95 unless the 2026 margin recovery fully reverses AND revenue growth goes negative, which would require a demand shock well beyond what GLP-1s or sugar regulation are currently producing. But I also don't see a 20% upside case to $170 unless the market re-rates the multiple on a growth inflection that the data doesn't yet support. This is a bond-with-a-kicker at current levels: the cash flows are real, the dividend is covered, but the equity story is "you get paid to wait" rather than "you get paid to be right."
What would flip me: a Q3 2026 print (due roughly late September) showing revenue growth below 1.5% YoY or operating margin back below 11% would confirm the 2026 recovery was a commodity blip and push me toward the overvalued camp. Conversely, two consecutive quarters of 12.5%+ operating margin with revenue growth above 2.5% would validate the 18x forward multiple and make me more comfortable holding. A dividend cut or a payout ratio above 100% would be an immediate red flag that the 4.18% yield is no longer sustainable. And if the 10-year Treasury yield climbs above 5%, the "defensive compounder" bid that has propped up this name loses its relative appeal versus risk-free alternatives.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue has compounded steadily from 79.5B in 2021 to 93.9B in 2025 (roughly 4.3% CAGR), with gross margin expanding from 53.3% to a 54.6% peak in 2024 before easing to 54.1% in 2025. Operating margin has been range-bound around 13-14% but slipped to 12.2% in 2025, and net income fell from 9.58B (2024) to 8.24B (2025) - the first real profit dip in the window. Cash conversion remains excellent: OCF/NI at 1.4x, accruals a clean -3.5% of assets, FCF of 7.67B in 2025, and Altman Z of 3.45 in the safe zone. Capital returns are disciplined - diluted share count actually shrank slightly (1.39B to 1.37B), SBC is just 0.3% of revenue, and buybacks run 2.75x SBC, so per-share value is protected. The balance sheet is the main constraint: net debt of roughly 40B against only 9.5B liquid cash means the company is self-funding but has no cushion, and dividend plus buyback commitments are financed against a leveraged base. Insider tape is unremarkable - routine awards and one small 405K sale, no meaningful directional signal. The 2025 margin and net income softness is the standout blemish in an otherwise textbook staples profile.
Verify before trusting this (5)
- Cause of 2025 operating margin compression (mix, restructuring charges, commodity, or organic volume weakness) in the 10-K MD&A
- Debt maturity ladder and weighted-average coupon given the -40B net debt position
- Organic volume trends by segment (Frito-Lay NA, PBNA, international) - are staples volumes actually declining?
- Any pending impairments or brand write-downs (Quaker recalls, juice divestitures) affecting 2025 GAAP results
- Pension and lease-adjusted leverage to confirm Altman Z read is not understated
The composite fair value sits at $107.86 and the signal-adjusted FV at $85.50, implying roughly 24-39% downside from $141.07. The anchored-PE of $150.67 is the only method that supports today's tape, and it essentially bakes in that PEP keeps earning its historical multiple despite flat volumes and a 2025 margin dent - a heroic assumption when the DCF ($110.35) and EPV floor ($60.06) both say the cash economics do not justify the price. Earnings quality is elite, so no haircut is warranted; the issue is not the numerator's honesty, it is that the market is paying a premium multiple for a business with structural volume and health headwinds. A Strong (not Fortress) staples franchise with 40B net debt deserves a solid multiple, but not a stretched one. My deserved value sits closer to $115-120 - I give some credit above the DCF for franchise durability and cash conversion, but I cannot get to $141 without assuming pricing power indefinitely offsets volume declines. That is roughly a 15-20% overpay, which puts this in Rich rather than Overvalued territory. The dividend and buyback cadence provide a floor, but not a margin of safety at this entry.
Verify before trusting this (4)
- 2026 organic volume trend by segment - Frito-Lay North America volume inflection is the swing factor
- Productivity program savings realization vs guidance
- Any change in dividend growth cadence signaling capital-allocation stress
- GLP-1 impact commentary on snacking demand in transcripts
The macro tape is mildly risk-on with a low VIX, which normally works against a 0.36-beta staple like PEP - money rotates to higher-octane names and defensives lag. But that rotation is stale news here: consumer staples have already underperformed in 2026, and the narrative pendulum is starting to swing back as commentators frame PEP as a lagging value/dividend play worth accumulating. Cramer name-checking PEP on Mad Money, multiple 'buy for the dividend' articles, and Barron's-style value-stock framing in the last 72 hours are the kind of retail-narrative amplifiers that firm up a floor.
Verify before trusting this (4)
- Whether staples-sector relative strength inflects (XLP vs SPY) in coming weeks
- Any GLP-1 or sugar-tax headline that could reignite the melting-ice-cube bear narrative
- Target revisions from major sell-side after next print - a downgrade cluster would flip this to headwind
- 10y yield direction - a move lower is a direct tailwind to bond-proxy staples
The world is not turning against packaged food and drink; it is turning against PepsiCo's center of gravity. Demand is migrating to functional, protein-forward, lower-sugar and private-label alternatives, and the retail channel is rewarding value packs and club formats over the impulse convenience occasions that Frito-Lay's DSD system was built to monetize. GLP-1 adoption and front-of-pack labeling are slow, cumulative pressures on high-calorie savory snacking rather than a cliff. Offsetting this, emerging-market snacking penetration is still rising and PepsiCo has real distribution there. Net: the category grows, the incumbent's specific occasions do not, so the business holds its earnings power through price, productivity and international mix rather than through unit demand.
When we made this prediction on Aug 31, 2026, PEP was $139.85. We expect it to be $134.00 by Mar 2027, and we consider it great value under $115.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 31, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.
Post-Report Due Diligence NOTES
Evidence for a closer look, not a verdict — no score or designation on this page has been changed by it. Items marked material are ones where a conclusion above moves to the other side of the price.
trailing_eps
flips down 25%
adjusted_pe
flips down 25%